+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension



Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension



American Journal of Physiology. Lung Cellular and Molecular Physiology 290(4): L723-L729



Phosphodiesterase 1 (PDE1) modulates vascular tone and the development of tolerance to nitric oxide (NO)-releasing drugs in the systemic circulation. Any role of PDE1 in the pulmonary circulation remains largely uncertain. We measured the expression of genes encoding PDE1 isozymes in the pulmonary vasculature and examined whether or not selective inhibition of PDE1 by vinpocetine attenuates pulmonary hypertension and augments the pulmonary vasodilator response to inhaled NO in lambs. Using RT-PCR, we detected PDE1A, PDE1B, and PDE1C mRNAs in pulmonary arteries and veins isolated from healthy lambs. In 13 lambs, the thromboxane A(2) analog U-46619 was infused intravenously to increase mean pulmonary arterial pressure to 35 mmHg. Four animals received an intravenous infusion of vinpocetine at incremental doses of 0.3, 1, and 3 mg.kg(-1).h(-1). In nine lambs, inhaled NO was administered in a random order at 2, 5, 10, and 20 ppm before and after an intravenous infusion of 1 mg.kg(-1).h(-1) vinpocetine. Administration of vinpocetine did not alter pulmonary and systemic hemodynamics or transpulmonary cGMP or cAMP release. Inhaled NO selectively reduced mean pulmonary arterial pressure, pulmonary capillary pressure, and pulmonary vascular resistance index, while increasing transpulmonary cGMP release. The addition of vinpocetine enhanced pulmonary vasodilation and transpulmonary cGMP release induced by NO breathing without causing systemic vasodilation but did not prolong the duration of pulmonary vasodilation after NO inhalation was discontinued. Our findings demonstrate that selective inhibition of PDE1 augments the therapeutic efficacy of inhaled NO in an ovine model of acute chemically induced pulmonary hypertension.

(PDF emailed within 0-6 h: $19.90)

Accession: 012216437

Download citation: RISBibTeXText

PMID: 16284211

DOI: 10.1152/ajplung.00485.2004


Related references

Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation 110(15): 2253-2259, 2004

Phosphodiesterase inhibition with dipyridamole augments and prolongs the pulmonary vasodilator response to inhaled nitric oxide in adults with chronic pulmonary hypertension. Circulation 98(17 SUPPL ): I614, Oct 27, 1998

Stimulation of soluble guanylate cyclase attenuates acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide. FASEB Journal 18(4-5): Abst 688 14, 2004

Sildenafil is a pulmonary vasodilator which augments and prolongs vasodilatation by inhaled nitric oxide in patients with pulmonary hypertension. Circulation 100(18 SUPPL ): I 240, Nov 2, 1999

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. American Journal of Cardiology 90(6): 677-680, 2002

Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. Journal of Applied Physiology 78(4): 1288-1295, 1995

Inhibition of cGMP specific phosphodiesterase decreases the threshold concentration of inhaled nitric oxide in lambs with persistent pulmonary hypertension of the newborn. Pediatric Research 37(4 PART 2): 80A, 1994

Effect of the phosphodiesterase inhibitor dipyridamole on inhaled nitric oxide in newborn lambs with persistent pulmonary hypertension. Pediatric Research 39(4 PART 2): 331A, 1996

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology 299(1): L109-L116, 2010

High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest 114(1 Suppl): 100s, 1998

Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatric Critical Care Medicine 5(3): 234-239, 2004

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92(6): 1702-1712, 2000

The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use. American Heart Journal 150(4): 725-728, 2005

Vasodilator response to inhaled nitric oxide is the most powerful predictor of survival in patients with pulmonary hypertension. Circulation 108(17 Supplement): IV-561, October 28, 2003

Inhaled nitric oxide in primary pulmonary hypertension The Perfect pulmonary vasodilator. Circulation 92(8 SUPPL ): I241, 1995